Early termination of clinical trials enrolling patients with breast cancer: Reasons, determinants, and temporal patterns

Study limitation reported by the research below: “The study spans 2001–2025, a period with major shifts in trial design and oncology drug development—temporal heterogeneity may confound pooled estimates.”